Recent studies reinforce that weight loss is not simply an esthetic consideration. It has very real benefits in terms of ...

Ozempic continues to grow in popularity in weight loss use. However, low-income patient populations who have an increased ...

Access to weight-loss drugs like Ozempic and Wegovy is far from equitable, with 90% going to patients with private insurance ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss ...

In under-resourced parts of Los Angeles, people develop life-altering, preventable diabetes complications related to obesity.

With the government—meaning taxpayers and out-of-control borrowing—picking up the tab, third-party coverage is likely to drive much greater demand for Medicare-subsidized Ozempic and home ...

It's no surprise that campaigning for office is largely a matter of buying votes with unrealistic promises of largesse to be funded—if the promise is ever fulfilled—on the backs of those to be ...

The study funded by Novo Nordisk, the manufacturer of Ozempic and Wegovy ... taking a placebo reported an average pain score of 43.4. Medicare can pay for obesity drugs like Wegovy in certain ...

All doses of Novo Nordisk’s blockbuster diabetes and obesity drugs were listed as available on the FDA shortage list as of ...